Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
2.636
-0.314 (-10.63%)
At close: Nov 4, 2024, 4:00 PM
2.800
+0.164 (6.21%)
Pre-market: Nov 5, 2024, 8:38 AM EST
Cyclerion Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Cash & Equivalents | 4.59 | 7.57 | 13.38 | 53.96 | 54.4 | 94.9 | Upgrade
|
| Cash & Short-Term Investments | 4.59 | 7.57 | 13.38 | 53.96 | 54.4 | 94.9 | Upgrade
|
| Cash Growth | -18.67% | -43.42% | -75.20% | -0.80% | -42.68% | - | Upgrade
|
| Receivables | - | - | 0.1 | 0.1 | 0.13 | 1.47 | Upgrade
|
| Prepaid Expenses | 0.12 | 0.44 | 0.81 | 0.93 | 2.42 | 1.97 | Upgrade
|
| Other Current Assets | 0.01 | 0.01 | 0.54 | 0.47 | 1.56 | 2.86 | Upgrade
|
| Total Current Assets | 4.72 | 8.02 | 14.82 | 55.46 | 58.5 | 101.2 | Upgrade
|
| Property, Plant & Equipment | - | - | 1.22 | 1.47 | 50.27 | 79.75 | Upgrade
|
| Long-Term Investments | 5.35 | 5.35 | - | - | - | - | Upgrade
|
| Other Long-Term Assets | - | - | 2.04 | 2.41 | 6.61 | 5.53 | Upgrade
|
| Total Assets | 10.07 | 13.37 | 18.08 | 59.33 | 115.38 | 186.48 | Upgrade
|
| Accounts Payable | 0.65 | 1.2 | 2.97 | 1.83 | 1.15 | 3.23 | Upgrade
|
| Accrued Expenses | 0.43 | 0.79 | 4.59 | 8.73 | 8.83 | 11.2 | Upgrade
|
| Short-Term Debt | - | - | - | - | 3.51 | - | Upgrade
|
| Current Portion of Leases | - | - | - | - | 3.29 | 3.42 | Upgrade
|
| Other Current Liabilities | 0.2 | 0.1 | 0.07 | 0.53 | 0.18 | 0.4 | Upgrade
|
| Total Current Liabilities | 1.28 | 2.09 | 7.63 | 11.09 | 16.95 | 18.25 | Upgrade
|
| Long-Term Leases | - | - | - | - | 38.93 | 70.5 | Upgrade
|
| Total Liabilities | 1.28 | 2.09 | 7.63 | 11.09 | 55.89 | 88.75 | Upgrade
|
| Additional Paid-In Capital | 276.08 | 275.72 | 269.63 | 263.35 | 222.95 | 183.38 | Upgrade
|
| Retained Earnings | -267.3 | -264.42 | -259.15 | -215.08 | -163.43 | -85.63 | Upgrade
|
| Comprehensive Income & Other | - | -0.01 | -0.02 | -0.02 | -0.03 | -0.02 | Upgrade
|
| Shareholders' Equity | 8.78 | 11.29 | 10.45 | 48.25 | 59.49 | 97.73 | Upgrade
|
| Total Liabilities & Equity | 10.07 | 13.37 | 18.08 | 59.33 | 115.38 | 186.48 | Upgrade
|
| Total Debt | - | - | - | - | 45.74 | 73.92 | Upgrade
|
| Net Cash (Debt) | 4.59 | 7.57 | 13.38 | 53.96 | 8.66 | 20.98 | Upgrade
|
| Net Cash Growth | -18.67% | -43.42% | -75.20% | 523.11% | -58.71% | - | Upgrade
|
| Net Cash Per Share | 1.85 | 3.24 | 6.16 | 27.57 | 5.70 | 15.32 | Upgrade
|
| Filing Date Shares Outstanding | 2.52 | 2.54 | 2.18 | 2.17 | 1.7 | 1.39 | Upgrade
|
| Total Common Shares Outstanding | 2.52 | 2.47 | 2.18 | 2.17 | 1.7 | 1.38 | Upgrade
|
| Working Capital | 3.43 | 5.94 | 7.19 | 44.37 | 41.55 | 82.95 | Upgrade
|
| Book Value Per Share | 3.49 | 4.56 | 4.80 | 22.23 | 34.95 | 70.82 | Upgrade
|
| Tangible Book Value | 8.78 | 11.29 | 10.45 | 48.25 | 59.49 | 97.73 | Upgrade
|
| Tangible Book Value Per Share | 3.49 | 4.56 | 4.80 | 22.23 | 34.95 | 70.82 | Upgrade
|
| Machinery | - | - | - | 0.05 | 0.04 | 16.4 | Upgrade
|
| Construction In Progress | - | - | - | - | - | 0.92 | Upgrade
|
| Leasehold Improvements | - | - | - | - | 14.89 | 13.67 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.